Terms and Conditions for Morivantexa Services

Please review these terms before using Morivantexa. They set expectations for use, safeguarding your rights and outlining our responsibility under Canadian law.

January 17, 2026

Acceptance of Terms

By accessing or using Morivantexa, you accept these terms as legally binding. Continued use indicates agreement, so please discontinue if you disagree.

Definitions

These terms refer to key definitions about platform, service, and user.

  • "Platform" means any digital platform operated by Morivantexa for providing automated trade recommendations.
  • "User" or "You" refers to individuals accessing, browsing, or using Morivantexa's services.
  • "Service" refers to AI-based automated recommendation delivery available through morivantexa.com.
  • “Content” covers information, data, trade signals, or materials displayed or transmitted through Morivantexa.

Acceptable Use of Service

Use services solely for your own informational purposes in compliance with Canadian law. Unauthorized commercial use is strictly prohibited.

Eligibility

To use Morivantexa, you must be at least 18 years old and have authority to agree to these terms, abiding by applicable law.

Service is not intended for minors under 18.

User Responsibilities

You agree to provide accurate information and respect platform security requirements at all times.

  • Maintain confidentiality of your account credentials.
  • Promptly notify us of suspected unauthorized access or misuse.
  • Follow applicable Canadian regulations regarding use of automated trade data.
  • Use service in a manner consistent with fair practice and these terms.

Prohibited Uses

The following uses are strictly not allowed.

  • Attempting to reverse engineer or disrupt security of the platform.
  • Transmitting any malicious code or engaging in fraudulent activity.
  • Sharing proprietary trade recommendations with unauthorized parties.
  • Using the service for unlawful or deceptive purposes.
  • Impersonating others or submitting misleading information.

Intellectual Property Notice

All contents, logos, methodologies, and recommendations available on Morivantexa are original works and property of the platform. Users receive a limited, non-transferable right of use.

User-Submitted Content

You may submit questions or feedback, provided these do not infringe any rights or applicable laws.

User Content Rights:

By submitting content, you grant Morivantexa a license to use, display, and process your feedback as needed to improve the service.

Your Privacy Rights and Policy

Your personal information is processed according to our Privacy Policy. We are committed to transparency, compliance, and safeguarding your privacy. Read Privacy Policy

Service Disclaimer and Limitations

All recommendations are informational and not financial instruction.

Essential Warnings:

Recommendations do not guarantee results; decisions rest with users. Past performance does not guarantee future results.

Limitation of Liability Statement

Morivantexa is not liable for indirect, consequential, or special damages. Users are responsible for evaluating all signals and outcomes.

Indemnification

You agree to indemnify Morivantexa against liability from your breaches of these terms or misuse of the platform.

Dispute Resolution Process

We aim to address disputes amicably; unresolved disputes are subject to procedures below.

Arbitration

Disputes will be settled by arbitration under applicable Canadian rules. Arbitration shall occur in the province Morivantexa operates.

Users consent to arbitration as sole remedy for unresolved disputes.

Online Dispute Resolution Information

Alternate pathways for dispute resolution may be available for platform users as applicable under Canadian law.

Read Full Disclaimer: Read Full Disclaimer

Applicable Law and Jurisdiction

This agreement is governed by the laws of Canada and the specific province of Morivantexa’s operations.

Termination

We reserve the right to terminate or suspend access for violations; users may stop using the platform at any time.

Modifications

These terms may be updated as required by legal, process, or policy changes. Continued use means acceptance of new terms.

Severability

If any provision is found invalid, other terms remain effective and enforceable.

Entire Agreement Understanding

These terms constitute the full agreement between Morivantexa and its users, overriding all prior communications.

Contact for Terms Questions

For questions regarding these Terms, reach out to us below.

Email Address: content@morivantexa.com

Phone Number: +1 (392) 214-9215

Mailing Address: 68 Water Street, Suite 401, Vancouver, BC V6B 1A4 Canada

Effective Date: January 17, 2026

Version: 1.2